Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 321-326

  Gregersen, Henrik ^a   Larsen, Caroline Brenner ^a   Haglund, Anne ^a   Mortensen, Rikke ^b   Andersen, Niels Frost ^b   Nørgaard, Mette ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Administrative data; Hospital discharge data; ICD 10; Monoclonal gammopathy of undetermined significance; Validation

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; DENMARK; DIAGNOSTIC REASONING; DISEASE CLASSIFICATION; DISEASE REGISTRY; ELECTROPHORESIS; FEMALE; HEALTH CARE SYSTEM; HEMATOLOGY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOCLONAL IMMUNOGLOBULINEMIA; MONOCLONAL IMMUNOGLOBULINEMIA OF UNDETERMINED SIGNIFICANCE; MYELOMA; POPULATION RESEARCH; PREDICTIVE VALUE; VALIDATION STUDY;

EID: 84883311464     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S50757     Document Type: Article

References (19)

1. Kyle RA, Therneau TM, Rajkumar SV, etal. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13): 1362-1369.
2. Rajkumar SV, Kyle RA, Therneau TM, etal. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005;106(3):812-817.
3. Gregersen H, Madsen KM, Sørensen HT, Schønheyder HC, Ibsen JS, Dahlerup JF. The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance. Eur J Haematol. 1998;61(2): 140-144.
4. Kristinsson SY, Tang M, Pfeiffer RM, etal. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood. 2010;116(15):2651-2655.
5. Kristinsson SY, Pfeiffer RM, Björkholm M, etal. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood. 2010;115(24): 4991-4998.
6. Gregersen H, Nørgaard M, Severinsen MT, Engebjerg MC, Jensen P, Sørensen HT. Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism. Eur J Haematol. 2011;86(2): 129-134.
7. Gregersen H, Jensen P, Gislum M, Jørgensen B, Sørensen HT, Nørgaard M. Fracture risk in patients with monoclonal gammopathy of undetermined significance. Br J Haematol. 2006;135(1):62-67.
8. Kristinsson SY, Tang M, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica. 2012;97(6):854-858.
9. Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996;25(2):435-442.
10. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
11. Andersen TF, Madsen M, Jørgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health science. Dan Med Bull. 1999;46(3):263-268.
12. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749-757.
13. Gregersen H, Mellemkjaer L, Ibsen JS, etal. Cancer risk in patients with monoclonal gammopathy of undetermined significance. Am J Hematol. 2000;63(1):1-6.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
15. Rago A, Grammatico S, Za T, et al. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form. Cancer. 2012;118(22):5544-5549.
16. Berenson JR, Anderson KC, Audell RA, etal. Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol. 2010;150(1):28-38.
17. Elis A, Radnay J, Shapiro H, Itzhaky D, Manor Y, Lishner M. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance? Isr Med Assoc J. 2006;8(12):840-842.
18. Berenson JR, Yellin O. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important. Clin Lymphoma Myeloma. 2009;9(4): 311-315.
19. Ghobrial IM. Are you sure this is Waldenstrom macroglobulinemia? Hematology Am Soc Hematol Educ Program. 2012;2012:586-594.